| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Amarin Corp Plc\uk (AMRN) has 5 insiders with recent SEC Form 4 filings, including 0 buys and 20 sells. AMRN is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 80.7K | $1.35M | - | |
| COO | 9.7K | $162.8K | - | |
| CFO | 6.4K | $107.9K | - | |
| VP | 3.7K | $61.8K | - | |
| VP | 2.2K | $36.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 10, 2019 | Zakrzewski Joseph S55 | Director | Sale+OE | 200,000 | $16.98 | $3,396,390.00 | -42.6% | |
| Jan 10, 2019 | Stack David M67 | Director | Sale+OE | 125,504 | $18.00 | $2,259,072.00 | -100% | |
| Jan 10, 2019 | Ekman Lars73 | Director | Sale+OE | 140,416 | $17.28 | $2,426,489.35 | -31.7% | |
| Jan 9, 2019 | Kalb Michael Wayne | SVP And CFO | Sale+OE | 200,000 | $15.26 | $3,051,080.00 | -92.0% | |
| Jan 2, 2019 | Zakrzewski Joseph S55 | Director | Sale+OE | 526,500 | $13.07 | $6,882,371.00 | -75.7% | |
| Dec 31, 2018 | Ketchum Steven B | Chief Scientific Officer | Sale+OE | 17,041 | $13.51 | $230,211.98 | -4.8% | |
| Dec 31, 2018 | Kennedy Joseph T | General Counsel | Sale+OE | 26,943 | $13.49 | $363,547.29 | -11.0% | |
| Nov 30, 2018 | Ketchum Steven B | Chief Scientific Officer | Sale+OE | 17,042 | $17.79 | $303,173.77 | -4.8% | |
| Nov 30, 2018 | Kennedy Joseph T | General Counsel | Sale+OE | 23,306 | $17.81 | $414,998.29 | -9.7% | |
| Nov 12, 2018 | Thero John F | President And CEO | Sale+OE | 607,611 | $19.07 | $11,587,896.18 | -6.3% |